Skip to main content
. 2018 Nov 12;12:3879–3883. doi: 10.2147/DDDT.S167149

Figure 3.

Figure 3

Psoriasis Area and Severity Index (PASI) 90 response rates at week 16 in Phase III clinical trial.

Note: Data from Blauvelt et al15 and Gordon et al.16